Biomaterial‐Based Defenders Boost Biopharmaceuticals Efficacy for Spinal Cord Injury Treatment: A Review
Abstract Spinal cord injury (SCI) has seriously affected the lives of patients and brought economic and medical burdens to society. Biopharmaceuticals, including transplanted cells, growth factors, enzyme drugs, and microRNA, present multidimensional therapeutic effects in tissue repair and regenera...
Main Authors: | Xunqi Zhang, Jian Cao, Jiahe Wu, Jian‐Qing Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley-VCH
2023-03-01
|
Series: | Advanced Materials Interfaces |
Subjects: | |
Online Access: | https://doi.org/10.1002/admi.202202034 |
Similar Items
-
Exosomes combined with biomaterials in the treatment of spinal cord injury
by: Xuanxuan Zhang, et al.
Published: (2023-03-01) -
Current Concepts of Biomaterial Scaffolds and Regenerative Therapy for Spinal Cord Injury
by: Hidenori Suzuki, et al.
Published: (2023-01-01) -
The Role of Biomaterials in Peripheral Nerve and Spinal Cord Injury: A Review
by: Ben Kaplan, et al.
Published: (2022-01-01) -
Nanosystems-enabled regenerative strategies for spinal cord Injury: Recent advances and future prospects
by: Zhiwei Jia, et al.
Published: (2024-01-01) -
Biomaterial-Supported Cell Transplantation Treatments for Spinal Cord Injury: Challenges and Perspectives
by: Shengwen Liu, et al.
Published: (2018-01-01)